Bumper Offer - Urjas oil Just @ Rs. 1
Takfa is a commercial drug that is prescribed in the form of Tablet, Ointment, Capsule, Lotion. It is typically used for the treatment of Liver transplant, Kidney transplant, Heart Transplant. Other than this, Takfa has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Takfa depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Takfa side effects, there are can be others also. These have been listed below. These side effects of Takfa are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Takfa's effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Takfa has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Takfa related warnings section.
Takfa can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Takfa in conditions like Infections, Diabetes Type 2. Other contraindications of Takfa have been discussed in the sections ahead.
Besides this, Takfa may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Takfa is safe while driving, and is is addictive in nature.
Takfa is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Takfa safe for pregnant women?
Pregnant women may experience moderate side effects from Takfa. It is best to stop taking Takfa immediately and inform your doctor if you notice any discomfort.
Is the use of Takfa safe during breastfeeding?
Breastfeeding women may feel side effects of Takfa. If you see any side effects, stop taking Takfa immediately and talk to your doctor. Take Takfa again, only after your doctor's advice.
What is the effect of Takfa on the Kidneys?
There can be some harmful effects on your kidneys after taking Takfa. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Takfa on the Liver?
The liver can be affected by Takfa. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Takfa only after medical advice.
What is the effect of Takfa on the Heart?
Takfa may have severe effects on your heart, so do not take it without first consulting your doctor.
Takfa should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Takfa unless your doctor advises you to do so -
Is this Takfa habit forming or addictive?
Forming a habit of Takfa has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Takfa since it does not cause drowsiness.
Is it safe?
Yes, but consume Takfa only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Takfa for mental disorders.
Interaction between Food and Takfa
Due to a lack of research, nothing can be said about the consequences of taking Takfa together with food.
Interaction between Alcohol and Takfa
Consumption of alcohol and Takfa together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
